Cardiology

Trials, guidelines and practice across cardiovascular medicine.

Perindopril-Amlodipine Cohort Tracks Blood Pressure Control in Hypertension

A prospective Bosnian cohort will follow 600 adults with uncontrolled hypertension on fixed-dose perindopril-amlodipine for blood pressure, adherence, and safety.

By Dr. Aishwarya N., MBBS · Oct 23, 2026 · 6 min read

Cardiology·ClinicalTrials

Renal Denervation Trial Tests Longer Ablation for Hypertension

A randomized Chinese trial will compare 1-minute versus 2-minute main renal artery ablation to see whether longer renal…

Oct 23, 2026

Cardiology·BMJ

Sirolimus-Coated Balloon Lowers Reintervention in Femoropopliteal Disease

In SirPAD, sirolimus-coated balloon angioplasty reduced 1-year target-lesion revascularization in femoropopliteal disease without tissue loss.

Oct 23, 2026

Cardiology·DailyMed

Olmesartan/Hydrochlorothiazide Label Adds Fetal Toxicity and Safety Warnings

DailyMed’s updated label for olmesartan/hydrochlorothiazide reinforces fetal toxicity, renal and electrolyte monitoring, and key drug interactions.

Oct 23, 2026

Cardiology·DailyMed

Amlodipine-Benazepril Label Reaffirms Fetal Toxicity and Renal Risks

DailyMed’s updated label for amlodipine and benazepril details fetal toxicity, angioedema, renal risk, hyperkalemia, and approved hypertension use.

Oct 23, 2026

Cardiology·medRxiv

Large Language Models in Cardiovascular Prevention Need Supervised Use

A narrative review maps how large language models may aid cardiovascular prevention while warning against hallucinations, privacy risks,…

Oct 23, 2026

Cardiology·medRxiv

Respiratory Failure Mortality Rising With Atrial Fibrillation in Older U.S. Adults

CDC WONDER data show a more than fivefold rise in respiratory failure deaths with atrial fibrillation or flutter…

Oct 23, 2026

Cardiology·medRxiv

Antarctic Deployment Cardiovascular Risk Models Diverge in U.S. Screening Cohort

Risk calculators disagreed in U.S. Antarctic Program candidates, with PREVENT aligning better than PCE and targeted imaging suggested…

Oct 23, 2026

Cardiology·Nature

Cardiac Fibrosis Review Maps Fibroblast Biology and New Targets

A Nature review examines human cardiac fibrosis, fibroblast heterogeneity, immune cross-talk, biomarkers, and emerging anti-fibrotic therapies.

Oct 23, 2026

Cardiology·BMJ Open

Strain Imaging Shows Strong CAD Signal in CABG-Range Disease

Prospective study of 510 chest pain patients found strain imaging performed well for CABG-level coronary disease but poorly…

Oct 23, 2026

Cardiology

Trials, guidelines and practice across cardiovascular medicine.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.